BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer
Clinical trial NCT00528567 · COMPLETED
Trial details
- NCT number
- NCT00528567
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2012-02-01
- Enrollment
- 2591
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.